Biostatistics and Computational Biology Program The Biostatistics and Computational Biology Program carries out quantitative and computational research in a variety of areas relevant to understanding issues related to cancer. Program interests span a range of activities, from the technical development of quantitative or experimental methodologies to activities that emphasize substantive research programs in epidemiology, to biological research programs that use experimental approaches alongside computational methods. Program strengths include the development of rigorous statistical and mathematical methods for personalized medicine and molecular diagnostics, understanding the molecular biology of the adaptive immune response, and the development of approaches that address high impact opportunities in cancer research - including methods for the analysis of complex association studies and longitudinal data, and experimental/ computational methods that characterize variations in quantity, sequence, and structure of the human genome, transcriptome, and proteome. The program members also have leadership activities that impact cancer research at a national level, including a number of U01s, a variety of statistical coordinating centers -- the Southwest Oncology Group (SWOG), the National Wilms Tumor Study, the Women's Health Initiative (WHI), the Statistical Centers for the HIV/AIDS Research & Prevention (SCHARP), and the Early Detection Research Network (EDRN) - and the leadership of multiple widely adopted computing platforms. The goals of the program are (i) to develop rigorous statistical and mathematical methods relevant to predictive and personalized medicine; (ii) to develop and use experimental, technological, and companion computational or mathematical methods to gain understanding of the natural history of cancer; and (iii) to promote development, dissemination and use of statistical and computational methods in cancer research. The Biostatistics and Computational Biology Program has 42 members, 93% of whom have external funding or are new faculty members, across two institutions, three schools and seven departments. Members published a total of 813 papers in the previous grant period. Program members are highly collaborative and routinely work with epidemiological, clinical, and laboratory-based researchers in other programs to support the translation of our expertise across the CCSG - 54% of our manuscripts were inter-programmatic, 10% were intra- programmatic, and 19% inter-institutional . Our members have been successful in obtaining funding to support their research programs. Peer reviewed funding (direct) is $10.9M of which $5.4M is from NCI, and includes many single-investigator R01s, several U01s, a longstanding P01, a variety of other peer reviewed grants or fellowships, and large-scale collaborative working groups.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-44
Application #
9617732
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
44
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Briant, Katherine J; Sanchez, Janeth I; Ibarra, Genoveva et al. (2018) Using a Culturally Tailored Intervention to Increase Colorectal Cancer Knowledge and Screening among Hispanics in a Rural Community. Cancer Epidemiol Biomarkers Prev 27:1283-1288
Xu, Chang; Nikolova, Olga; Basom, Ryan S et al. (2018) Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer. Clin Cancer Res 24:2828-2843
Miller, Chris P; Tsuchida, Connor; Zheng, Ying et al. (2018) A 3D Human Renal Cell Carcinoma-on-a-Chip for the Study of Tumor Angiogenesis. Neoplasia 20:610-620
Baker, K Scott; Syrjala, Karen L (2018) Long-term complications in adolescent and young adult leukemia survivors. Hematology Am Soc Hematol Educ Program 2018:146-153
Gavvovidis, Ioannis; Leisegang, Matthias; Willimsky, Gerald et al. (2018) Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus. Clin Cancer Res 24:3644-3655
Paulson, K G; Voillet, V; McAfee, M S et al. (2018) Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. Nat Commun 9:3868
Puronen, Camille E; Cassaday, Ryan D; Stevenson, Philip A et al. (2018) Long-Term Follow-Up of 90Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma. Biol Blood Marrow Transplant 24:2211-2215
Witzky, Anne; Hummels, Katherine R; Tollerson 2nd, Rodney et al. (2018) EF-P Posttranslational Modification Has Variable Impact on Polyproline Translation in Bacillus subtilis. MBio 9:
Rosenthal, Elisabeth A; Shirts, Brian H; Amendola, Laura M et al. (2018) Rare loss of function variants in candidate genes and risk of colorectal cancer. Hum Genet 137:795-806
Verboon, Jeffrey M; Decker, Jacob R; Nakamura, Mitsutoshi et al. (2018) Correction: Wash exhibits context-dependent phenotypes and, along with the WASH regulatory complex, regulates Drosophila oogenesis (doi:10.1242/211573). J Cell Sci 131:

Showing the most recent 10 out of 1267 publications